<DOC>
	<DOCNO>NCT01327222</DOCNO>
	<brief_summary>The purpose study compare effectiveness intravitreal bevacizumab injection ( IVBI ) respect simple observation patient subfoveal choroidal neovascularisation ( CNV ) secondary age-related macular degeneration ( AMD ) present baseline best correct visual acuity ( BCVA ) less 20/200 .</brief_summary>
	<brief_title>Intravitreal Bevacizumab Low Vision Neovascular Age-related Macular Degeneration ( AMD )</brief_title>
	<detailed_description>There clear indication regard treatment patient subfoveal choroidal neovascularisation ( CNV ) secondary age-related macular degeneration ( AMD ) present baseline best correct visual acuity ( BCVA ) less 20/200 . Treatment eye low visual acuity could lead waste resource , without functional social improvement . Aim present study compare effectiveness intravitreal bevacizumab injection ( IVBI ) respect simple observation</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<mesh_term>Vision , Low</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>agerelated macular degeneration na√Øve subfoveal choroidal neovascularization bestcorrected visual acuity le 20/200 previous treatment condition able limit visual improvement</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>age-related macular degeneration</keyword>
	<keyword>bevacizumab</keyword>
</DOC>